PharmaIN, Corp.
Biotechnology ResearchWashington, United States11-50 Employees
PharmaIN is a clinical-stage biopharmaceutical company dedicated to developing first- and best-in-class subcutaneous therapies through peptide engineering.
Innovative Focus PharmaIN's specialization in developing first- and best-in-class subcutaneous therapies through peptide engineering positions it as a leader in cutting-edge biotech solutions, offering opportunities for collaboration in novel therapeutics and advanced drug delivery technologies.
Strategic Partnerships The company's recent partnership with NanoTemper Technologies highlights its openness to integrating advanced screening technologies, which could facilitate joint development projects and enhance R&D capabilities.
Growing Revenue With an estimated revenue between $10 million and $25 million and a funding of $1.5 million, PharmaIN shows promising financial health, suggesting potential for expanding operations and the need for scalable technological solutions.
Technology Stack Utilizing diverse web and software tools such as Yoast SEO, Apache, and jQuery Validation, PharmaIN demonstrates a readiness for digital engagement and innovative tech adoption, creating opportunities for IT and digital solution providers.
Market Positioning Operating within the competitive biotech sector with smaller size relative to giants like Omeros Corporation, PharmaIN may benefit from targeted solutions that support growth, such as R&D automation, clinical trial management, or biotech marketing services.
PharmaIN, Corp. uses 8 technology products and services including Open Graph, Slider Revolution, Smartsheet, and more. Explore PharmaIN, Corp.'s tech stack below.
| PharmaIN, Corp. Email Formats | Percentage |
| FLast@pharmain.com | 77% |
| Last@pharmain.com | 15% |
| First.Last@pharmain.com | 5% |
| First-Last@pharmain.com | 3% |
Biotechnology ResearchWashington, United States11-50 Employees
PharmaIN is a clinical-stage biopharmaceutical company dedicated to developing first- and best-in-class subcutaneous therapies through peptide engineering.
PharmaIN, Corp. has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on May 16, 2014 in the amount of $1.5M.
PharmaIN, Corp.'s revenue is estimated to be in the range of $10M$25M
PharmaIN, Corp. has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on May 16, 2014 in the amount of $1.5M.
PharmaIN, Corp.'s revenue is estimated to be in the range of $10M$25M